BDX Jul 2024 245.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:18AM EDT. Market open.
| Previous close | 1.2500 |
| Open | 1.7000 |
| Bid | 2.7500 |
| Ask | 3.9000 |
| Strike | 245.00 |
| Expiry date | 2024-07-19 |
| Day's range | 1.7000 - 4.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | 182 |
Investor's Business DailyEdwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal
Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson's plan to buy a key division for $4.2 billion.
PR NewswireBD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Edwards Lifesciences (NYSE: EW), today announced a definitive agreement under which BD will acquire Edwards' Critical Care product group ("Critical Care"), a global leader in advanced monitoring solutions, for $4.2 billion in cash, unlocking new value creation opportunities and enhancing BD's portfolio of smart connected care solutions.
ZacksBD's (BDX) FDA-Approved Test to Offer Wider Testing Access
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.
© 2024 Yahoo. All rights reserved.